Company Background

About Medexus Inc.


Medexus has a strong Canadian position as an innovator with new and existing products. Key areas include: Rheumatology, Women’s health and Dermatology. Growth comes from clinically proven safe and effective brands, market knowledge, product value and unique consumer and healthcare professional relationships.

Beyond our Borders

Medexus has key partnerships around the globe–We value and respect our partners and are committed to continued growth in current and new therapeutic areas.

Calcia, a European leader and formerly an unknown in the Canada marketplace, is now leading the chewable market in Canada.

Metoject, another European leader, not only improves quality of life for RA patients, but is a safer alternative to current products.



Solving unmet needs in the healthcare environment bringing safe, effective unique products to the market providing a better quality of life.


Innovation as a driving force Medexus continuously licenses or acquires new products and solutions aimed at addressing the essential needs of consumers, patients and health care partners.


Focusing on trust and transparency within our organization, as well as with our customers and partners. We commit to maintaining the highest level of product quality on the market.


Our vision is to provide the best healthcare products to Consumers and Healthcare Professionals, through our core values of Quality, Customer Service, Innovation and Teamwork.